Arlo Technologies Reports Strong Q4 Results and Upbeat Guidance
Arlo Technologies shares surged 31.20% as the stock reached a 20-day high amid strong Q4 results and optimistic guidance.
The company reported adjusted earnings of 22 cents per share for Q4, exceeding Wall Street's expectation of 16 cents, with revenue rising 16% year-over-year to $141.3 million, surpassing the anticipated $135.6 million. Additionally, Arlo projected first-quarter adjusted earnings between 17 cents and 23 cents per share, with revenue expectations between $135 million and $145 million, both above analysts' forecasts, indicating robust performance in its subscription and services business.
This strong performance and positive outlook suggest that Arlo Technologies is well-positioned for continued growth, particularly in its subscription services, which are key drivers of profitability.
Trade with 70% Backtested Accuracy
Analyst Views on ARLO
About ARLO
About the author

- Equity Award Program: On May 5, 2026, Arlo Technologies granted 556,850 shares of restricted stock units (RSUs) and performance-vesting stock units (PSUs) to 25 new employees under its 2018 Equity Incentive Plan, highlighting the company's commitment to attracting talent.
- RSU and PSU Structure: Of the total, 464,638 shares are RSUs that vest in four equal annual installments, while 92,212 shares are PSUs that vest based on the company's achievement of financial targets related to annual recurring revenue and gross margin, reflecting a performance-driven incentive approach.
- Performance-Driven Incentives: The actual number of shares issuable under the PSUs will vary between 0-200% based on the company's performance relative to the targets, designed to motivate employees to contribute to the company's long-term success and enhance team cohesion.
- Continuous Service Requirement: All RSUs and PSUs are contingent upon each employee's continued service at the vesting date, ensuring the company retains key talent and promotes stable business growth.
- Equity Award Program: On May 5, 2026, Arlo Technologies granted 556,850 shares of restricted stock units (RSUs) and performance-vesting stock units (PSUs) to 25 new employees under its 2018 Equity Incentive Plan, emphasizing the company's commitment to attracting talent.
- RSUs and PSUs Structure: Of the total, 464,638 shares of RSUs will vest in four equal annual installments, while 92,212 shares of PSUs will vest based on the company's achievement of financial targets related to annual recurring revenue and gross margin, highlighting a strong focus on performance.
- Performance-Driven Incentives: The actual number of shares for PSUs will vary between 0-200% based on company performance, which not only motivates employees to achieve corporate goals but also strengthens their commitment to the company's long-term growth.
- Continued Service Requirement: All granted RSUs and PSUs are contingent upon each employee's continued service with the company at the vesting date, ensuring alignment of employee interests with the company's long-term objectives and enhancing team stability and cohesion.
- Acquisition Completed: Arlo Technologies has finalized its acquisition of Aloe Care Health, further expanding its software-as-a-service platform into aging-in-place and wellness care services, targeting the needs of the growing population aged 65 and older.
- Technology Enhancement: This transaction adds AI-powered medical alert and fall prevention capabilities to Arlo's product portfolio, not only enhancing its competitive edge in smart home services but also strengthening its position in the healthcare solutions market.
- Market Expansion Strategy: Arlo stated that the acquisition supports its strategy to expand into new markets with a focus on healthcare and caregiving solutions, which is expected to drive future business growth.
- Financial Outlook: Although the financial terms of the deal were not disclosed, Arlo projects service revenue to reach $375 million to $385 million by 2026, indicating a positive outlook driven by partnerships and its SaaS model.
- Sale Context: Brian Busse, General Counsel of Arlo Technologies, sold 25,525 shares for approximately $352K on March 12, 2026, primarily to cover tax withholding obligations related to 50,000 shares from a performance stock unit (PSU) plan.
- Ownership Reduction: This transaction reduced Busse's direct holdings by 4.19%, leaving him with 583,364 shares valued at about $7.88 million, underscoring his significant stake in the company.
- Financial Performance: Arlo Technologies reported its first net income in fiscal year 2025, with total revenue reaching $529.3 million and net income of $14.93 million, indicating strong growth potential in the smart home security sector.
- Stock Buyback Program: The company's board approved a $50 million stock repurchase program set to continue through December 31, 2027, which may further drive share prices up and enhance investor confidence.
- Share Increase: Rice Hall James & Associates acquired 574,877 shares of QuidelOrtho in Q4 2026, reflecting confidence in the company's future prospects despite a 43.4% decline in stock price over the past year.
- Investment Value: This acquisition raised QuidelOrtho's stake to 1.3% of the fund's 13F reportable assets, indicating recognition of its potential value, which may attract further investor interest.
- Market Performance: As of February 13, 2026, QuidelOrtho's market capitalization stood at $1.6 billion with a current price of $23.58, trailing the S&P 500 by 55.2 percentage points, highlighting competitive pressures in the market.
- Strategic Adjustments: QuidelOrtho is undergoing strategic adjustments, including strengthening its product pipeline and improving spending returns, with analysts expecting these efforts to yield modest revenue and operating profit growth in the coming years.
- Increased Holdings: Rice Hall James purchased 574,877 shares of QuidelOrtho in Q4, raising its total stake to 833,791 shares valued at $23.8 million, reflecting a positive outlook on the company's future prospects.
- Investment Value Growth: The position's value increased by $16.2 million at quarter-end, indicating a rise in stock price and additional share purchases, suggesting the fund's optimistic view on QuidelOrtho's potential value.
- Industry Position: As a leader in in vitro diagnostics, QuidelOrtho has struggled with consistent revenue growth and profitability in recent years, but its strategic adjustments and strengthened product pipeline may improve financial performance, attracting value investors.
- Market Expectations: Analysts expect QuidelOrtho to achieve modest revenue and operating profit growth in the coming years, although the Motley Fool analyst team did not include it in their list of top investment stocks, indicating a divergence in market perceptions of its potential.











